News
4d
MedPage Today on MSNEnd of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts SkyrocketResearchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...
Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...
Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...
As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...
The nation's plastic surgeons report their practices are busier than ever as patients want to plump facial features affected by weight loss.
The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people ... but the improvements in brain volume and cognitive function were statistically significant.
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
BARCELONA — GLP-1 medications took center stage at Vitafoods Europe, held May 20 to 22 in Barcelona. Discussions at the show ...
Primary care providers can use a new clinical advisory guideline to nutritionally support patients who are using GLP-1 ...
Vivani Medical is developing GLP-1 subdermal implants that aim to provide a consistent therapeutic dose for six months, and ...
Discover how the breakthrough pill orforglipron matches injectable weight loss drugs in effectiveness while offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results